A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

Clinical trial NCT07222488 · RECRUITING

Trial details

NCT number: NCT07222488
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Urinary Bladder Neoplasms

Start date: 2025-12-09
Primary completion: 2029-02-28
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.